Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Can J Physiol Pharmacol ; 85(2): 185-92, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17487259

RESUMO

Iron deficiency is the most common human nutritional disorder in the world. Iron absorptive capacity of the small intestine is known to be much limited and therefore large quantities of iron salts must be used to treat iron deficiency. As a result, significant amounts of iron may reach the large intestine. This study compared the capacities of the small and large intestine to transfer luminal iron to the venous blood in relationship with the expression in epithelial cells of proteins involved in iron absorption using a pig model. Intracaecal injection of iron sulphate corresponding with 2.5 and 5.0 mg elemental iron per kg body mass resulted in modest, transient, but significant (p<0.05) increases in iron concentration in the portal blood plasma. By comparing portal blood plasma iron concentrations following injection in the duodenal and caecal lumen, we calculated that 5 h after injection, iron colonic absorption represented approximately 14% of duodenal absorption. Caecal and proximal colon mucosa accumulated iron to a much lower extent than the duodenal mucosa. Isolated colonocytes were found to express divalent metal transporter (DMT1) and ferritin, but to a lesser extent than the duodenal enterocytes. Ferroportin was highly expressed in colonocytes. In these cells as well as in enterocytes ferroportin was found to be glycosylated. In short term experiments and at a concentration in the range of that measured in the aqueous phases recovered from the large intestine luminal content after iron injection, iron sulphate did not alter colonocyte viability. We concluded that the colonic epithelial cells that express proteins involved in iron absorption are able to transfer luminal iron to the venous blood even if its relative participation in the overall intestinal absorption appears to be modest under our experimental conditions.


Assuntos
Colo/metabolismo , Duodeno/metabolismo , Absorção Intestinal , Ferro/metabolismo , Animais , Proteínas de Transporte de Cátions/análise , Sobrevivência Celular , Colo/citologia , Duodeno/citologia , Enterócitos/metabolismo , Ferritinas/análise , Mucosa Intestinal/metabolismo , Suínos
2.
J Nutr Biochem ; 16(7): 398-401, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15992677

RESUMO

Hydrolysis of proteins could lessen their inhibiting effect on the poor absorption of cow's milk iron (Fe), which is responsible for the high incidence of Fe deficiency worldwide. When bound to Fe, caseinophosphopeptides (CPP) derived from milk proteins resist luminal digestion, enhance Fe solubility and could improve its bioavailability; brush border enzyme alkaline phosphatase activity could influence iron absorption by releasing free Fe; this study assessed its role in the absorption of CPP-bound Fe. Rat duodenal loops were perfused with Fe gluconate or Fe bound to the CPP of beta casein [beta-CN (1-25)], with or without the addition of an inhibitor of alkaline phosphatase, Na2WO4. The uptake of Fe-beta-CN (1-25) was greater than Fe gluconate. Na2WO4 enhanced the uptake of Fe-beta-CN (1-25) and not of Fe gluconate. So the release of free, insoluble Fe, by alkaline phosphatase seems to be prevented by providing Fe in the Fe-beta-CN (1-25) complex form. Its good disappearance rate makes beta-CN (1-25)-bound Fe a candidate for food fortification.


Assuntos
Fosfatase Alcalina/metabolismo , Caseínas/farmacocinética , Ferro/farmacocinética , Fragmentos de Peptídeos/farmacocinética , Fosfatase Alcalina/antagonistas & inibidores , Animais , Disponibilidade Biológica , Inibidores Enzimáticos/farmacologia , Técnicas In Vitro , Absorção Intestinal , Perfusão , Fosforilação , Ratos , Ratos Sprague-Dawley , Compostos de Tungstênio/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA